Return on Tangible Equity (Annual)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Taysha Gene Therapies, Inc. (TSHA) had Return on Tangible Equity of -44.14% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$9.77M
Net Income	$-109.00M
Cost of Goods Sold	--
Gross Profit	$9.77M
Operating Expenses	$120.27M
Operating Income	$-110.50M
Non-Operating Income/Expense	$1.50M
Pre-Tax Income	$-109.00M
Normalized Pre-Tax Income	$-109.00M
Income after Taxes	$-109.00M
Income from Continuous Operations	$-109.00M
Consolidated Net Income/Loss	$-109.00M
Normalized Income after Taxes	$-109.00M
EBIT	$-110.50M
EBITDA	$-109.35M
Weighted-Average Shares Outstanding (Basic)	319.71M
Weighted-Average Shares Outstanding (Diluted)	319.71M
Earnings per Share (EPS) (Basic)	$-0.34
Earnings per Share (EPS) (Diluted)	$-0.34
Balance Sheet Financials
Current Assets	$324.65M
Property, Plant, and Equipment	$6.74M
Long-Term Assets	$18.67M
Total Assets	$343.32M
Current Liabilities	$26.55M
Long-Term Debt	$50.11M
Long-Term Liabilities	$69.83M
Total Liabilities	$96.38M
Common Equity	$246.94M
Tangible Shareholders Equity	$246.94M
Shareholders Equity	$246.94M
Common Shares Outstanding	285.05M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-93.09M
Cash Flow from Investing Activities	$-0.60M
Cash Flow from Financial Activities	$274.59M
Beginning Cash	$141.64M
End Cash	$322.53M
Increase/Decrease in Cash	$180.90M
Stock-Based Compensation	$13.30M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	12.23
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.17
Debt to Equity Ratio	0.20
Gross Margin	100.00%
Operating Margin	-1130.65%
EBIT Margin	-1130.65%
EBITDA Margin	-1118.93%
Pre-Tax Profit Margin	-1115.27%
Profit Margin	-1115.27%
Free Cash Flow	$-93.83M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.03
Inventory Turnover	--
Receiveable Turnover	--
Days Sales in Receivables	--
Return on Equity	-44.14%
Return on Tangible Equity	-44.14%
Return on Assets	-31.75%
Return on Investments	-36.69%
Book Value Per Share	$0.87
Free Cash Flow per Share	$-0.29
Operating Cash Flow per Share	$-0.29

Data from Zacks Investment Research, Inc.